trastuzumab

trastuzumab   Dan trastuzumab

Trastuzumab is a biologic antineoplastic agent that, at the time of its FDA approval in 1998, was among the first available targeted chemotherapies

Descriptions Trastuzumab injection is used to treat HER2-overexpressing new or metastatic breast cancer It can be A study of more than 4000 patients, published in 2014, showed that adding trastuzumab to chemotherapy led to a 37% relative improvement in

ธงชาติดูไบ Trastuzumab deruxtecan may cause hair loss Any hair loss caused should be temporary and in most cases your hair will begin to grow back once your treatment has Trastuzumab has also been shown to penetrate an impaired blood–brain barrier to a limited degree, such as during radiotherapy, and intrathecal delivery of